Indication
Adenocarcinoma of pancreas
Adenocarcinoma of the pancreas is an aggressive malignant neoplasm arising from the epithelial cells of the exocrine pancreas, predominantly originating in the pancreatic ductal system. Read more about Adenocarcinoma of pancreas
124 drugs 78 manufacturers
Drugs that treat it
Common Adenocarcinoma of pancreas therapies.
PACLITAXEL PROTEIN-BOUND
PACLITAXEL PROTEIN-BOUND
FAVLYXA (fluorouracil)
PACLITAXEL PROTEIN-BOUND
MITOMYCIN
RASONQUE (daraxonrasib)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAdenocarcinoma of the pancreas is an aggressive malignant neoplasm arising from the epithelial cells of the exocrine pancreas, predominantly originating in the pancreatic ductal system.
Primarily affecting older adults, it most commonly develops in the head of the pancreas and is pathologically characterized by an extensive desmoplastic stroma, invasive duct-like structures, and frequent somatic alterations such as KRAS mutations.
Due to a lack of early specific symptoms, patients frequently present at advanced stages with painless obstructive jaundice, unintentional weight loss, epigastric pain radiating to the back, vascular encasement, or distant metastatic disease.
- wikipedia.org
Adenocarcinoma of the pancreas is an aggressive malignant neoplasm arising from the epithelial cells of the exocrine pancreas, predominantly originating in the pancreatic ductal system
- nih.gov
Adenocarcinoma of the pancreas is an aggressive malignant neoplasm arising from the epithelial cells of the exocrine pancreas, predominantly originating in the pancreatic ductal system
- nih.gov
Primarily affecting older adults, it most commonly develops in the head of the pancreas and is pathologically characterized by an extensive desmoplastic stroma, invasive duct-like structures, and frequent somatic alterations such as KRAS mutations Due to a lack of early specific symptoms, patients frequently present at advanced stages with painless obstructive jaundice, unintentional weight loss, epigastric pain radiating to the back, vascular encasement, or distant metastatic disease
- nih.gov
Primarily affecting older adults, it most commonly develops in the head of the pancreas and is pathologically characterized by an extensive desmoplastic stroma, invasive duct-like structures, and frequent somatic alterations such as KRAS mutations Due to a lack of early specific symptoms, patients frequently present at advanced stages with painless obstructive jaundice, unintentional weight loss, epigastric pain radiating to the back, vascular encasement, or distant metastatic disease
- nih.gov
Primarily affecting older adults, it most commonly develops in the head of the pancreas and is pathologically characterized by an extensive desmoplastic stroma, invasive duct-like structures, and frequent somatic alterations such as KRAS mutations
- medlineplus.gov
Due to a lack of early specific symptoms, patients frequently present at advanced stages with painless obstructive jaundice, unintentional weight loss, epigastric pain radiating to the back, vascular encasement, or distant metastatic disease
Personalize your experience
Follow Adenocarcinoma of pancreas and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.